AI-Driven Cancer Treatment Developed in Just 30 Days, Also Predicts Patients’ Life Expectancy

By: | March 27th, 2023

Image by Pixabay

Artificial intelligence (AI) has revolutionized the world, transforming the way we live and work.

AI has enormous potential in the field of medicine, and its application in healthcare is only increasing. It could lead to more widely available treatments for all patients, regardless of their socioeconomic status.

AI is the new weapon against deadly diseases

Researchers from the University of Toronto in collaboration with Insilico Medicine have developed a potential treatment for hepatocellular carcinoma (HCC), the most common form of liver cancer, using AI-powered tools.

Researchers used AlphaFold, an artificial intelligence (AI)-powered protein structure database, and an AI drug development platform called to treat hepatocellular carcinoma (HCC) that claims 700,000 lives annually.

By using these technologies, the researchers found a previously undiscovered treatment route and created a ‘novel hit molecule’ that could bind to that target.

It significantly reduced the development of cancer in clinical trials

The AI model was able to pick up on unique clues within a patient’s medical records to provide a more nuanced assessment. Whereas traditionally cancer survival rates have been calculated retrospectively and categorized by a few factors like cancer site and tissue type.

The AI was trained using data from 47,625 patients across all six British Columbia Cancer sites

The application of AI significantly cut down on the amount of time and effort required for such a study. What used to take years of trial and error is a matter of just a few weeks now.

Nidhi Goyal

Nidhi is a gold medalist Post Graduate in Atmospheric and Oceanic Sciences.

More articles from Industry Tap...